Navigation Links
Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
Date:3/10/2008

l information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our ability to close the financing transaction, early results from our clinical trial, Access' plans to continue and initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-KSB and other reports filed by Access with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
2. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
3. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
4. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
5. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Fenwal Inc., a global medical technology company focused ... announced today that the U.S. Food and Drug ... ® platelet additive solution. Fenwal ® ... product used in combination with human plasma to ... to prevent or treat bleeding. ,, InterSol ® ...
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, Systemic Lupus ... Market Forecasts to 2015 ,, ... Lupus Erythematosus - Drug Pipeline Analysis ... Summary ,, GlobalData, the ...
(Date:12/15/2009)... -- EnzySurge Ltd.,(EnzySurge), a provider of innovative ... announced today that it has received clearance ... to market its new,SilverStream(TM) solution for prescription ... version of the SilverStream product. , ... of the DermaStream(R) product line.,DermaStream is a ...
Breaking Medicine Technology:Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 1Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 2Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 3Harvard research team receives 2410M NSF grant to develop small scale mobile robotic devices 9541 4Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 1Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 2Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 3Cempra Pharmaceuticals Announces Appointment of John H Johnson to Board of Directors 13526 1Cempra Pharmaceuticals Announces Appointment of John H Johnson to Board of Directors 13526 2Cempra Pharmaceuticals Announces Appointment of John H Johnson to Board of Directors 13526 3
... to President Obama,s call for "a cure for cancer ... America (PhRMA) delivered a new report today on medicines ... that America,s pharmaceutical research and biotechnology companies are testing ... medicines listed in the report are being tested in ...
... We may introduce the first,"A"- Implant novelty from Austria: , , ... - two-part system, - extraordinary stability, ... reliable Zirconium oxide, - Manufactured for your individual odontotherapy!, ... After 4 years of research and technical development, the team ...
Other Medicine Technology:New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 2New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 3New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 4
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., ... that, "it doesn,t matter whether there,s a public option. ... public option - give government authority over how your ... new social agenda by shifting billions of dollars from ... immigrants, and local politicians." ,, Betsy McCaughey ...
(Date:12/15/2009)... The new compact LifeSpan TR200 folding treadmill, made by ... was highly praised by treadmill review groups in recent ... TR200 folding treadmill received awards for Best New Treadmill, ... ,, The compact LifeSpan TR200 treadmill is designed for ... category buster is a very compact treadmill that could ...
(Date:12/15/2009)... Strike Force Operations Lead to Indictment of 30 ... more than $61 Million in Fraudulent Billing to ... -- Thirty people have been charged in three ... submit more than $61 million in false Medicare ... the Medicare Fraud Strike Force, Department of Health ...
(Date:12/15/2009)... new study links chronic obstructive pulmonary disease, or COPD, ... to activate the body,s immune system. , The ... growing awareness of the immune system,s role in COPD, ... 12 million Americans with wheezing, shortness of breath, chest ... if doctors are to find better ways to detect ...
(Date:12/15/2009)... United Nations Foundation has led the fight against malaria, ... Report 2009 that the global strategies for ending malaria deaths are ... the United Nations Foundation , ... Washington, D.C. (Vocus) ... Nations Foundation has led the fight against malaria, and I ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2
... PMD ) today announced that Jennifer Chmieleski ... Jennifer will be responsible for all internal and ... analysis and planning,activities necessary for the company,s continued ... CEO. Since 1999, Jennifer has served as ...
... ... management support circle, ALEXANDRIA, Va., Oct. 4 ... tool that,makes it easier for people with diabetes -- and ... to improve their diabetes,care. The tool, My Diabetes Connector, is ...
... 4 Diet.com has joined Microsoft Corp. ... newly launched Microsoft,HealthVault consumer health platform. ... include,Diet.com Calorie/Meal Tracker, Diet.com Weight Tracker, and ... HealthVault. The trackers will,enable users to share ...
... (Nasdaq: GNTA ) announced today that the Company,s ... will provide an,update of corporate activities at the BIO ... PDT. The conference will be held at The,Palace hotel ... webcast and accessible at the Investor,Relations section of the ...
... developed for the industry, PHILADELPHIA, Oct. ... division, announced today that it is among ... new Pharmacy Benefit,Management Standards. Nearly 70 ... pharmacy benefit management companies. URAC accreditation provides,assurance ...
... Institute of Child Health and Human Development (NICHD) announced ... was awarded a competitive contract to participate in the ... be conducted in the United States to assess the ... human health. The study will follow 100,000 children from ...
Other Medicine News:Health News:Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 3Health News:New Diabetes Tool Available on American Diabetes Association Web Site 4Health News:Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault 2Health News:Genta to Present at Bio Investor Forum 2007 Conference 2Health News:Genta to Present at Bio Investor Forum 2007 Conference 3Health News:PerformRx Earns New URAC Accreditation for Pharmacy Benefit Management 2Health News:UMASS Medical School awarded National Children's Study contract 2Health News:UMASS Medical School awarded National Children's Study contract 3Health News:UMASS Medical School awarded National Children's Study contract 4
Girard angled tying forceps made of titanium has angled 45 shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 102 mm....
McPherson curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 85 mm....
Tying forceps with flat serrated handle 88 mm, made of titanium, angled 30 with 4.5 mm tying platform....
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Medicine Products: